Uncommon Non-MS Demyelinating Disorders of the Central Nervous System

Area of Science:

• Neurology and Immunology
• Central Nervous System (CNS) Disorders
• Diagnostic Advancements in Neuroimmunology

Background:

• Definitive diagnosis of Multiple Sclerosis (MS) necessitates excluding other Central Nervous System (CNS) disorders with similar clinical, pathological, and radiological features.
• A review of uncommon disorders that mimic MS, focusing on differentiation strategies, is crucial for accurate diagnosis and management.

Purpose of the Study:

• To review and discuss uncommon CNS disorders that mimic Multiple Sclerosis (MS).
• To emphasize clinical and radiological differentiation of these mimics from MS.
• To highlight recent diagnostic advances in distinguishing MS from other demyelinating and non-demyelinating CNS conditions.

Main Methods:

• Review of scientific literature focusing on differential diagnosis of MS.
• Analysis of clinical, pathological, and radiological features of MS mimics.
• Discussion of diagnostic criteria updates, including the revised McDonald criteria incorporating the central vein sign (CVS) and paramagnetic ring lesions (PRL).

Main Results:

• Recognition of neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte antibody disorder (MOGAD) as distinct entities, differentiated from MS by specific antibodies (AQP4, MOG) and distinct clinical/imaging features.
• Updated McDonald criteria for MS diagnosis now include MRI markers like CVS and PRL, and CSF kappa free light chains (kFLC).
• Various other conditions, including autoimmune (e.g., antiphospholipid syndrome, Behcet disease), autoinflammatory, infectious, neoplastic, and genetic disorders (e.g., leukodystrophies), can mimic MS.

Conclusions:

• Accurate MS diagnosis relies on excluding a wide spectrum of mimicking CNS disorders.
• Advances in serological testing for NMOSD and MOGAD, along with refined imaging criteria for MS, significantly improve diagnostic accuracy.
• A comprehensive understanding of both demyelinating and non-demyelinating mimics is essential for optimal patient care.